🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Experimental Drug Gaining Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are encouraged to message these accounts directly for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with thousands of participants share “before and after” images, administration instructions and claims of rapid British shipping. Vendors market the substance there before directing buyers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Express Concerns

Nevertheless, physicians and chemists have cautions that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could result in individuals administering substances of unknown origin.

Several experts stated the popularity for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach medicines, marketing, and customer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Reaction and Content Elimination

According to TikTok, the service has removed violative content and banned related keywords and search suggestions. The company stated it was dedicated to keeping the platform safe and allocating resources in strengthening compliance measures.

Online Marketplace Operations

Research also discovered groups with up to 9,000 members marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, populated with images of weight loss, positive testimonials and step-by-step guides for preparing or administering at residence.

After minutes of joining one community, a seller shared WhatsApp details, where most transactions take place. The seller provided an instruction manual and promised shipping within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about body mass, health issues or previous experience.

Item Information and Costs

Within these groups, messages display dark colored packages with postal service labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how much time a injector should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram said it regularly monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they can’t verify. Even if the research behind retatrutide is valid, these digital versions may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But fake injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has already seen patients harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they explained, adding that any item “falsely representing itself as a company experimental product not yet authorized … may expose users to possibly significant health risks”.